Ittai Harel

Ittai currently serves on the Board of Directors of DouxMatok, EarlySense, Medisafe, Clew Medical, Tscan, Vertos Medical and Visby Medical. He also serves as the Chairman of the Board at EarlySense.

His investments focus on Digital Health, Health-IT and MedTech, and he brings with him over 15 years of experience in Venture Capital as well as 20 years of experience in operations and management roles.

Before joining Pitango, Ittai headed Corporate Development at Nektar Therapeutics (NASDAQ: NKTR), served as Executive Vice President roles at IDGene Pharmaceuticals and IDEXX Laboratories (NASDAQ: IDXX).

Ittai holds a BSc in Chemical Engineering and Biotechnology from Ben-Gurion University, and an MBA from the MIT Sloan School of Management.